Rock Creek Pharmaceuticals, Revenue Growth Rates (RCPI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rock Creek Pharmaceuticals, Inc.  (RCPI)
 

RCPI's Revenue Growth by Quarter and Year

Rock Creek Pharmaceuticals,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RCPI Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00





RCPI Revenue second quarter 2016 Y/Y Growth Comment
Rock Creek Pharmaceuticals, Inc. in the second quarter 2016 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2016, Rock Creek Pharmaceuticals, Inc. achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Rock Creek Pharmaceuticals, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2016.


RCPI Revenue ( Y/Y Growth %) 2016
 2015 2014 2013
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - 1875 % -
FY   - - 1875 % -

Financial Statements
Rock Creek Pharmaceuticals,'s second quarter 2016 Revenue $ 0.00 millions RCPI's Income Statement
Rock Creek Pharmaceuticals,'s second quarter 2015 Revenue $ 0.00 millions Quarterly RCPI's Income Statement


RCPI Revenue (Quarter on Quarter Growth %)

 2016
 2015 2014 2013
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - -8.86 % -
1st Quarter March - - - -
FY (Year on Year)   - - 1875 % -


Back to RCPI Growth rate Comparisons >> Back to RCPI Growth rate Comparisons >>


Revenue second quarter 2016 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2016 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2013, 2014, 2015, 2016

Rock Creek Pharmaceuticals,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RCPI's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RCPI's II. Quarter Q/Q Revenue Comment


Rock Creek Pharmaceuticals,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2016)		 12 Months Ending
(Mar 31 2016)		 12 Months Ending
(Dec 31 2015)		 12 Months Ending
(Sep 30 2015)		 12 Months Ending
(Jun 30 2015)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jun 30 2016 period, Rock Creek Pharmaceuticals,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Rock Creek Pharmaceuticals, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2016 period, Rock Creek Pharmaceuticals,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Rock Creek Pharmaceuticals, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RCPI's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Jun 30 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2016
Acer Therapeutics Inc 0.00%$ 0.000 millions
Precision Optics Corporation Inc -0.02%$ -0.024 millions
Alphatec Holdings Inc -0.28%$ -0.285 millions
3m Company-0.31%$ -0.312 millions
Diversicare Healthcare Services Inc -0.50%$ -0.502 millions
Seaspine Holdings Corporation-0.78%$ -0.777 millions
Quest Diagnostics Inc-0.99%$ -0.987 millions
Qc Technologies Inc -1.08%$ -1.079 millions
Cas Medical Systems Inc-1.24%$ -1.241 millions
Luna Innovations Inc-1.24%$ -1.244 millions
Fresh Tracks Therapeutics Inc -1.29%$ -1.293 millions
Wellness Center Usa Inc-1.45%$ -1.452 millions
Standard Biotools Inc -1.57%$ -1.572 millions
Myriad Genetics Inc -1.78%$ -1.783 millions
Microbot Medical Inc -2.72%$ -2.721 millions
Alerislife Inc -2.87%$ -2.872 millions
Hanger inc.-3.07%$ -3.071 millions
Invo Fertility Inc -3.57%$ -3.571 millions
Ocular Therapeutix Inc -3.92%$ -3.922 millions
Invacare Holdings Corporation-3.92%$ -3.925 millions
Atrion Corporation-4.02%$ -4.015 millions
Misonix Inc -5.23%$ -5.226 millions
Rti Surgical Holdings Inc -5.57%$ -5.571 millions
Vericel Corporation-5.64%$ -5.644 millions
Gilead Sciences Inc -5.68%$ -5.677 millions
Community Health Systems Inc -5.77%$ -5.771 millions
Bruker Corporation-6.14%$ -6.136 millions
Bioxytran Inc -6.35%$ -6.347 millions
Accuray Incorporated-6.66%$ -6.660 millions
Axim Biotechnologies Inc -7.19%$ -7.191 millions


About Rock Creek Pharmaceuticals, Revenue Growth Rates (RCPI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.